COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Immunohistochemical Study of Matrix
Metalloproteinase-1 (MMP-1) Expression in
Oral Submucous Fibrosis
Dissertation submitted to
THE TAMILNADU DR. M. G. R. MEDICAL UNIVERSITY
In partial fulfillment for the Degree of
MASTER OF DENTAL SURGERY
BRANCH IV
ORAL AND MAXILLOFACIAL PATHOLOGYMarch 2007
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
ACKNOWLEDGEMENT
I extend my sincere thanks to Dr. K. Ranganathan, MDS, MS (Ohio), Professor and
Head, Department of Oral and Maxillofacial Pathology, Ragas Dental College and Hospital,
for his valuable guidance, support, encouragement and all help throughout my post graduate
curriculum. I thank him for the time spent on going through my work, giving ideas and
correcting all the minute mistakes without which this thesis could not be presented in the
present form.
My heartful gratitude to Dr. T. R. Saraswathi, MDS, M.Sc (Lon), Professor, for her
constant encouragement and valuable advices throughout my post graduate course.
I extend my sincere thanks to Dr. M. Uma Devi, Professor, Department of Oral and
Maxillofacial Pathology, Ragas Dental College and Hospital, for her guidance, support and
help throughout my post graduate curriculum, and various advices in completion of this
work.
I earnestly thank Dr. Elizabeth Joshua, Associate Professor, Department of Oral and
Maxillofacial Pathology, Ragas Dental College and Hospital for her constant
encouragement and support throughout my study.
I thank Dr. S. Nalin Kumar, Reader and Dr. S. Balasundaram & Dr. Sandhya,
Lecturers, Department of Oral and Maxillofacial Pathology, Ragas Dental College and
Hospital, who helped me with their guidance throughout my post graduate course.
Sincere thanks to the Principal, Dr. S. Ramachandran, Ragas Dental College and
Hospital for his permission to use the facilities of the institution.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
I extend my sincere thanks to Research Assistant Mrs. Kavitha, Bio-statistician Mrs.
Hemalatha, Lab Technician Mr. Rajan, Ragas Dental College and Hospital, for all the
patience shown and the constant help they rendered in completion of this study.
I wish to thank Computer Assistant Mrs. Rupa, Ragas Dental College and Hospital,
for her valuable help.
I acknowledge gratefully all my batch mates Dr. Antony, Dr. Jayanthi, Dr. Raghu,
Dr. Siva and Dr. Vidya, all my seniors & juniors, for their constant help and support
throughout my postgraduate life & my friends Dr. Ghazan and Dr. Vidya KM for being there
when I needed them.
I would like to dedicate my work to my parents Sri. Brajesh Mishra & Dr. Manju
Mishra, for their sacrifices, abundant support, faith, understanding and love & my
Grandmother for her prayers and blessings. I would like to remember my beloved Late
Grandfather whose teachings and ideologies have always been my source of inspiration.
Last but not the least, I thank God Almighty, the Supreme Being without whose will
nothing would have been possible.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
CONTENTS
S. No. INDEX PAGE No.
1. INTRODUCTION 1
2. AIMS AND OBJECTIVES 4
3. MATERIALS AND METHODS 5
4. STATISTICAL ANALYSIS 15
5. REVIEW OF LITERATURE 16
6. RESULTS 50
7. TABLES AND GRAPHS 55
8. PHOTOMICROGRAPHS 65
9. DISCUSSION 71
10. SUMMARY AND CONCLUSION 76
11 BIBLIOGRAPHY 77
12. ANNEXURE 92
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Introduction
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Oral submucous fibrosis (OSF) is a form of pathological fibrosis affecting the oral
mucosa and contiguous areas of the upper aerodigestive tract, having a relentless course of
progression 63. The condition was aptly described by Sirsat and Pindborg as “an insidious
chronic disease affecting any part of the oral cavity and sometimes pharynx. Although
occasionally preceded by and/or associated with vesicle formation, it is always associated
with juxtaepithelial inflammatory reaction followed by fibroelastic changes in the lamina
propria, with epithelial atrophy leading to stiffness of the oral mucosa causing trismus and
difficulty in eating” 51.
WHO definition for an oral precancerous condition- “a generalized pathological state
of the oral mucosa associated with a significantly increased risk of cancer”, accords well with
the characteristics of OSF 59.
OSF predominantly involves the oral cavity. Buccal mucosa, retromolar area and the
soft palate are the most commonly involved sites. Other sites include floor of the mouth,
oropharynx, and tongue. The mucosa in the involved site becomes pale followed by
progressive stiffness.
It occurs predominantly in the Indian subcontinent and South Asian countries where
this habit is more prevalent. The frequency of the population affected by OSF ranges from
35% to 100% 37.
There is compelling evidence to implicate the habitual chewing of arecanut with the
development of OSF. Arecoline, an active alkaloid found in betel nuts, stimulates fibroblasts
to increase production of collagen by as much as 150%. Flavanoids, catechin, and tannin in
arecanut cause collagen fibers to cross-link, making them less susceptible to collagenase 37.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Since collagens are the major structural components of connective tissues, including
oral submucosa, the composition of collagen within each tissue needs to be precisely
regulated to maintain tissue integrity13. Collagenase among other enzymes plays an important
role in this process. Collagenase is a type of matrix metalloproteinase (MMP).
MMPs are a family of neutral proteases that are produced by variety of cells during
both physiologic conditions like normal development, wound healing and wide variety of
pathological processes 40.
Currently 26 human MMPs have been identified and these enzymes have been
classified according to their substrate specificity and structural similarities. They are
produced by several cell types including fibroblasts, macrophages, neutrophils, synovial cells
and some epithelial cells. Their secretion is induced by certain stimuli, including growth
factors, cytokines and physical stress 31.
Collagenase, a member of the MMP family, is secreted as a latent precursor
(procollagenase) and is activated by chemicals, such as free radicals produced during the
oxidative burst of leukocytes and proteinases 31. Collagenase is the principal human enzyme
that cleaves native fibrillar collagen 13. Collagenase-1 (MMP-1) is produced by a wide
variety of normal cells, eg. stromal fibroblasts, macrophages, endothelial cells and epithelial
cells, as well as by numerous tumors, suggesting a broad-base role for this collagenase in
biology 6.
MMP expression in various tissue types has been examined through
immunohistochemical analysis and insitu hybridization26. Collagenase activity has been
found to be lower in OSF than in the normal oral mucosa. This implies that OSF may be a
collagen-metabolic disorder resulting from alkaloid exposure and individual variation in
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
collagen metabolism13. This study was carried out to evaluate the expression of MMP-1 in
OSF and in normal mucosa.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Aims & Objectives
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
AIM
1. To evaluate the expression of Matrix Metalloproteinase (MMP) -1 in different
histological grades of oral submucous fibrosis (OSF) by immunohistochemistry in
paraffin embedded tissues.
2. To evaluate the expression of MMP-1 in normal buccal mucosal tissues by
immunohistochemistry in paraffin embedded tissues.
3. To compare the expression of MMP-1 in OSF and normal buccal mucosa.
HYPOTHESIS
Matrix Metalloproteinase-1 (MMP-1) expression is decreased in oral submucous
fibrosis (OSF).
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Materials & Methods
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Study setting
The study was conducted in the Department of Oral and Maxillofacial Pathology,
Ragas Dental College and Hospital, Chennai, to study the expression of MMP-1 in OSF by
immunohistochemistry in paraffin embedded tissues.
Study subject
The study comprised of 2 groups:
Group 1- (CASES)
o 30 consecutive patients of OSF, diagnosed clinically and confirmed
histopathologically, were selected.
o Inclusion Criteria-
Clinical:
x Habit of chewing arecanut in some form.
x The presence of fibrous bands in the labial and/ or buccal
mucosa.
x Loss of elasticity of the buccal/ labial mucosa.
x Restriction of mouth opening.
Histopathological:
x Juxtaepithelial hyalinization.
x Submucosal dense and vascular collagenous connective tissue.
x Epithelial atrophy
x Variable number of chronic inflammatory cells 63.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Group 2- (CONTROLS)
o 10 patients who had clinically normal buccal mucosa, reporting to the out
patient Department of Oral and Maxillofacial Surgery for removal of impacted
third molar constituted the control group.
o Inclusion Criteria-
They had no habit of smoking, alcohol consumption or chewing
arecanut.
They were apparently healthy with no systemic disorders.
They were not on any medications.
Methodology
1. A detailed case history including age, sex, occupation, past medical & dental history,
history of habits, drugs and trauma were recorded.
2. General examination and intra oral examination was done.
3. Biopsy was done in both cases and controls.
a. Group 1- The site for biopsy was the region of maximum palpable fibrotic
bands in the buccal mucosa.
b. Group 2 - Normal buccal mucosa adjacent to the site of extraction of impacted
3rd molar was taken for biopsy.
c. Incisional biopsy of sufficient width and depth to ensure inclusion of
connective tissue was taken from buccal mucosa.
4. The tissue taken was immediately transferred to 10 % buffered formalin.
5. After adequate fixation, tissues were embedded in paraffin.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
6. From the paraffin embedded blocks 5 micron thick, sections were cut and used for
routine hematoxylin and eosin (H & E) staining and immunohistochemical (IHC)
staining.
HEMATOXYLIN & EOSIN STAINING
Reagents
x Harry’s hematoxylin
x 1% acid alcohol
x Eosin
Procedure
x The slides were dewaxed in xylene and hydrated through graded alcohol to water.
x The sections on the slides were flooded with Harry’s hematoxylin for 5 minutes.
x The slides were washed in running tap water for 5 minutes.
x The slides were differentiated in 1% acid alcohol for 5 minutes.
x The slides were washed well in running tap water for 5 minutes.
x The tissue sections on the slides were then stained in Eosin for 30 seconds.
x The slides were washed in running tap water for 1 minute.
x The slides were then dehydrated through alcohol, cleared, mounted and viewed under
light microscope.
IMMUNOHISTOCHEMISTRY (IHC)
Armamentarium
x Microtome
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
x Autoclave
x Hot air oven
x Slide warmer
x Couplin jars
x Measuring jar
x Weighing machine
x APES coated slides
x Slide carrier
x Aluminium foil
x Micro-pipettes
x Toothed forceps
x Electronic timer
x Beakers
x Rectangular steel tray with glass rods
x Sterile gauze
x Cover-slips
x Light microscope
Reagents used
1. conc. HCl
2. Laxbro soln
3. APES ( 3 amino propyl tri ethoxy silane)
4. Acetone
5. Tri-sodium citrate buffer
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
6. Tri-phosphate buffer saline (TBS)
7. 3% H2O2
8. Deionized distilled water
9. Haematoxylin
10. Absolute alcohol
11. Xylene
Antibodies used
1. Primary antibody
Anti-MMP-1 Mouse Monoclonal Antibody, Clone: 41-1E5; Isotype: IgG2a
(Calbiochem – Merck International EMD Biosciences, Cat. No. IM35L)
2. Secondary antibody
IHC Select Immunoperoxidase Secondary Detection System.
(Chemicon International, Cat. No. DAB150)
IHC Procedure
Pretreatment of the slides
x The slides were first washed in tap water for few minutes
x The slides were then soaked in detergent solution for 1 hour
x After 1 hour, each slide was brushed individually using the detergent solution and
were transferred to distilled water.
x The slides were washed in two changes of distilled water.
x The slides were washed in autoclaved distilled water.
x The slides were immersed in 1 N HCL (100 ml HCl in 900 ml distilled water)
overnight.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
x The following day slides were taken out of acid and washed in two changes of
autoclaved distilled water.
x All the slides were then transferred to slide trays, wrapped in aluminium foil and
baked in hot air oven for 4 hours at 180 degrees centigrade.
APES (3 Amino propyl tri ethoxy silane) coating
Slides first dipped in couplin jar containing acetone for 2 minutes
Dipped in APES for 5 minutes
Dipped in two changes of distilled water for 2 minutes each
Slides left to dry
Preparation of paraffin sections
After the slides were dry, tissue section of 5 micron thickness were made in a rotary
manual microtome. The ribbons of tissue section were transferred onto the APES coated slide
from the tissue float both such that two tissue bits come on to the slide with a gap in between.
One of the tissue sections was labeled positive (P) and the other negative (N).
Procedure
The slides with tissue sections were treated with three changes of xylene to
remove paraffin wax. They were put in descending grades of alcohol and then rehydrated
with water. Slides were then treated with 5% hydrogen peroxide for 20 minutes to quench
endogenous peroxidase activity of cells that would otherwise result in non – specific staining.
The slides were then put in two changes of distilled water. Then the slides were transferred to
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
citrate buffer and autoclaved for antigen retrieval at 15 lbs pressure for 15 minutes. The
slides were then washed in two changes of distilled water. Then the slides were dipped in 3
changes of Tri-phosphate buffer saline (TBS) for 5 minutes each. The slides were then wiped
carefully without touching the tissue section with gauze to remove excess TBS. Circles were
drawn around the tissues, so that the antibodies added later on do not spread and are
restricted to the circle. Blocking reagent was added to both the specimens and incubated for 5
minutes. The sections taken out were washed in three changes of cold TBS for 5 minutes in
each. Then the slides were wiped carefully without touching the tissue section to remove
excess TBS. The primary antibody, Anti-MMP-1 Mouse Monoclonal Antibody, 1:40 dilution
was added to P tissue on the slide and then to the N TBS was added. The slides were
incubated for 1 hour. The sections taken out were washed in three changes of cold TBS for 5
minutes in each to remove the excess antibody. Then the slides were wiped carefully without
touching the tissue section to remove excess TBS. Then a drop of biotnylated link from
secondary antibody kit, was added on both the sections and the slides were incubated for 20
minutes. Later slides were washed in three changes of cold TBS for 5 minutes in each. The
slides were wiped carefully without touching the tissue section to remove excess TBS. Then
a drop of Streptavidin- Horse Radish Peroxidase (HRP) from the secondary antibody kit was
added on both the sections and the slides were incubated for 10 minutes. The sections were
washed in 3 changes of cold TBS for 5 minutes in each. Then the slides were wiped carefully
without touching the tissue section to remove excess TBS. Then a drop of freshly prepared
DAB (3’ – Diaminobenzidine Tetra Hydrochloride – a substrate chromogen) was added on
both sections. Slides were then washed in running distilled water to remove excess DAB and
counter stained with hematoxylin. The slides were placed in a tray with tap water for bluing.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Then the slides were transferred to 70% alcohol, 100% alcohol and two changes of xylene.
The tissue sections were mounted with DPX. The slides were then observed under the
microscope. Throughout the procedure care was taken not to dry the tissues.
Positive Control
Breast carcinoma specimen tissues were fixed, processed, embedded, sectioned and
stained in same manner and used as positive control. One positive control tissue slide was
included for each batch of staining.
Observations
The mounted slides were viewed under the light microscope. The positively stained
MMP-1 cells take up brown color within the cytoplasm. The intensity was evaluated and
graded using the staining intensity of the breast carcinoma tissues (positive control) as:
¾ (-) negative
¾ (+) mild
¾ (++) moderate
¾ (+++) intense staining
(Photomicrograph 1, 2)
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
IHC PROCEDURE FLOW CHART
APES coated slides with 2 paraffin embedded tissues
Placed in xylene thrice (5 minutes each)
Placed in 100% isopropanol (5minutes)
Placed in 70% isopropanol (5minutes)
Washed in distilled water thrice (5 minutes each)
Placed in 3% hydrogen peroxide (20 minutes)
Washed in distilled water thrice (5 minutes each)
Kept in citrate buffer at pH 6 and autoclaved at 210C at 121psi for Antigen retrieval
and bench cooled for 40 minutes
Washed in TBS thrice (5 minutes each)
Blocking reagent added to both specimens and incubated at room temperature in an enclosed
hydrated container (5 minutes)
Washed in TBS thrice (5 minutes each)
Primary antibody added to study specimen and incubated in an enclosed hydrated container
(1 hour)
Washed in TBS thrice (5 minutes each)
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Secondary antibody added and incubated in an enclosed hydrated container
(20 minutes)
Washed in TBS thrice (5 minutes each)
Streptavidin HRP added and incubated in an enclosed hydrated container
(10 minutes)
Washed in TBS thrice (5 minutes each)
DAB added and incubated in an enclosed hydrated container (5 minutes)
Washed in TBS thrice (5 minutes each)
Stained with haematoxylin (1 minute)
Washed in tap water
Placed in ammonia (1 minute)
Washed in tap water
Placed in 70% isopropanol (5 minute)
Placed in 100% isopropanol (5 minute)
Placed in xylene twice (5 minutes each)
Slides were mounted using DPX
Slides were observed under the LM and graded
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Statistical Analysis
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Data entry was performed and analysed with the aid of Statistical Package for Social
Sciences (SPSS 10.0.5 version). Descriptive analysis was presented for all the variables. Chi-
square test of association was used to find out the difference in expression of MMP-1
between oral submucous fibrosis (OSF), normal buccal mucosa and among different
histological grading of OSF. A p value < 0.05 was considered significant.
Kappa analysis was performed for measurement of agreement with a second
evaluator to assess inter-observer variation.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Review of Literature
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
ORAL SUBMUCOUS FIBROSIS
Oral submucous fibrosis (OSF) is a chronic, progressive, scarring disease that
predominantly affects the people of South-East Asian origin. It is considered to be a
premalignant stage of oral cancer, affecting predominantly Indians and other Asians 33.
HISTORY
Sushruta (400 BC)69 the ancient Indian medical text-describes a condition termed
“VIDARI” under mouth and throat diseases as progressive narrowing of mouth,
depigmentation of oral mucosa and pain on taking food.” All these are characteristics of
OSF.
Schwartz J (1952)68 while examining five Indian women from Kenya ascribed the
descriptive term “atrophia idiopathica mucosae oris” to this chronic progressive scarring
disease.
Joshi SG (1953)28 an otolaryngolygist from Bombay redesignated the condition as
“oral submucous fibrosis”, implying predominantly its histological nature.
Lal D (1953)34 observed and named the condition as “diffuse oral submucous
fibrosis”.
Rao RV (1954)65 examined and termed the condition as “Idiopathic palatal fibrosis”.
Su IP (1954)76 was the one who called the condition as “Idiopathic scleroderma of
the mouth”.
Behl PN (1957)4 suggested to name the condition as “Sclerosing stomatitis”.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
GEOGRAPHIC DISTRIBUTION
Schwartz J (1952)68 first described the condition among five East African women of
Indian origin.
Lal D and Joshi SG (1953)34 were the first to report a case of oral submucous from
India.
Su IP (1954)76 was the first one to report oral submucous fibrosis among non-Indians
from Taiwan.
Pindborg JJ and Sirsat SM (1966)55 stated that it occurs predominantly in India,
Southeast Asia, the South Pacific Islands and South Africa.
Laskaris G, Bovopoulou O and Nicolis G (1981)35 reported a case of OSF in a 67
year old Greek female.
Canniff JJ (1986)8 were the first to report 27 cases of oral submucous fibrosis from
UK.
Rajendran R (2003)59 reported about a survey of Indian villages and the prevalence
of OSF as 0.2% in Gujarat, 0.4% in Kerala, 0.4% in Andhra Pradesh and 0.07% in Bihar.
Ariyawardana A, Athukorala ADS and Arulanandam A (2006)2 reported the
cases of OSF from Sri Lanka.
ETIOLOGY
Etiological agents proposed in the pathogenesis of OSF are as following:
Arecanut
Arecanut is the endosperm of the fruit of the Areca catechu tree.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Lal D (1953)3 4 stated that all cases without exception gave history of chewing
“supari” (Hindi word for betel nut).
Paissat DK (1981)51 observed that in the three new cases in his study, all chewed
betelnut. He suggested betelnut as a common denominator in the occurrence of severe
changes in oral mucosa both in India and Papua New Guinea.
Sinor PN, Gupta PC, Murti PR et al (1990)73 confirmed arecanut as the most
important etiologic factor in OSF.
Rajendran R, Radhakrishnan NS, Kartha CC et al (1993)60 stated that chewing
arecanut can be an important etiologic factor of OSF.
Maher R, Lee AJ, Warnakulasuriya KAAS et al (1994)39 inferred that habit of
chewing betel nut is the most important etiologic factor in pathogenesis of OSF.
Murti P R (1995)47 calculated the incidence of OSF from a 10-yr prospective study
and results underscored the usual role of arecanut chewing in OSF.
Chang YC, Tai KW, Li CK et al (1999)9 stated that arecoline is the main alkaloid of
arecanut, which may inhibit fibroblast proliferation and collagen synthesis and thereby cause
OSF.
Rajendran R (2003)5 9 stated that there is compelling evidence to implicate the
habitual chewing of arecanut with development of OSF.
Ranganathan K, Devi MU, Joshua E et al (2004)63 conducted a case-control study
and confirmed a strong association between arecanut use and OSF.
Chilli consumption
Sirsat SM and Khanolkar VR (1962)6 8 studied 85 palatal biopsies from OSF
patients and hypothesized chilli as an etiological agent. They reported that “capsaicin”, one
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
of the ingredients of chilli, produced mild changes in the connective tissue in wistar rats
similar to oral submucous fibrosis.
Laskaris G (1981)35 conducted an experimental study on wistar rats using capsaicin
and inferred that capsaicin was capable of evoking a limited connective tissue response in an
unimpaired animal system.
Chiu CJ, Chang ML, Chiang CP et al (2002)13 conducted a case control study betel
quid chewers with OSF and betel quid chewers without OSF, and found no association
between OSF and chilli\ hot pepper consumption.
Nutritional deficiency
Pindborg JJ, Chawla TN, Srivastav AN et al (1965)5 4 reported clinical and
pathological changes of OSF in vitamin B and protein deficient animals.
Ramanathan K (1981)57 summarized the evidence for OSF being a mucosal change
secondary to chronic iron and\or vitamin B complex deficiency.
Genetic susceptibility
Canniff JP, Harvey W and Harris M (1986)8 stated that the patients have a genetic
predisposition which renders their oral mucosa susceptible to chronic inflammatory changes
if they chew betel nut.
CLINICAL FEATURES
Paissat DK (1981)51 observed the most initial symptoms as burning sensation in
mouth while eating spicy food followed by vesicle formation, ulceration or recurrent
stomatitis with excessive salivation, defective gustatory sensation and dryness of mouth.
Later there is difficulty in mouth opening, inability to whistle and difficulty in swallowing.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Canniff JP, Harvey W and Harris M (1986)8 reported the major features of OSF as:
x Burning sensation with hot or spicy food
x Progressive inability to open the mouth
x Sudden onset of inflammation
x Oral ulcerations
x Dry mouth
x Difficulty in mastication, speech and swallowing
x Shrinkage and deformity of uvula
x Depapillation of tongue.
Pindborg JJ (1989)37 clinically divided OSF into 3 stages and the physical findings
vary accordingly, as follows:
x Stage 1: Stomatitis includes erythematous mucosa, vesicles, mucosal ulcers,
melanotic mucosal pigmentation, and mucosal petechia.
x Stage 2: Fibrosis occurs in ruptured vesicles and ulcers when they heal, which is the
hallmark of this stage.
o Early lesions demonstrate blanching of the oral mucosa.
o Older lesions include vertical and circular palpable fibrous bands in the buccal
mucosa and around the mouth opening or lips, resulting in a mottled marble
like appearance of the mucosa because of the vertical, thick, fibrous bands
running in a blanching mucosa. Specific findings include the following:
Reduction in the mouth opening (trismus)
Stiff and small tongue
Blanched and leathery floor of the mouth
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Fibrotic and depigmented gingiva
Rubbery soft palate with decreased mobility
Blanched and atrophic tonsils.
Shrunken budlike uvula.
Sunken cheeks, not commensurate with age or nutritional status.
x Stage 3: Sequelae of OSF are as follows:
o Leukoplakia is precancerous and is found in more than 25% of individuals
with OSF.
o Speech and hearing deficits may occur because of involvement of the tongue
and the eustachian tubes.
Khanna JN and Andrade NN (1995)30 developed a group classification system for the
surgical management of OSF:
¾ Group I: Very early cases.
Common symptom is burning sensation in the mouth.
Acute ulceration and recurrent stomatitis
Not associated with mouth opening limitation.
x Histology:
Fine fibrillar collagen network interspersed with marked edema.
Blood vessels dilated and congested.
Large aggregate of plump, young fibroblasts present with abundant
cytoplasm.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Inflammatory cells mainly consists of polymorphonuclear leukocytes with few
eosinophils.
Epithelium normal and nonkeratinised.
¾ Group II: Early cases.
Buccal mucosa appears mottled and marble-like.
Widespread sheets of fibrosis palpable.
Patients with an interincisal distance of 26-35 mm.
x Histology:
Juxtaepithelial hyalinization is present.
Collagen present as thickened but separate bundles.
Blood vessels are dilated and congested.
Young fibroblasts seen in moderate number.
Inflammatory cells mainly consists of polymorphonuclear leukocytes with few
eosinophils and occasional plasma cells.
Flattening or shortening of epithelial rete pegs evident with varying degree of
keratinization.
¾ Group III: Moderately advanced cases.
Trismus evident, with an interincisal distance of 15-25 mm.
Buccal mucosa appears pale and firmly attached to underlying tissues.
Atrophy of vermilion border.
Vertical fibrous bands palpable at the soft palate, pterygomandibular raphe
and anterior faucial pillars.
x Histology:
Juxtaepithelial hyalinization is present.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Thickened collagen bundles faintly discernible, separated by very slight,
residual edema.
Blood vessels, mostly constricted.
Mature fibroblasts with scanty cytoplasm and spindle-shaped nuclei.
Inflammatory exudate consists mainly of lymphocytes and plasma cells.
Epithelium markedly atrophic with loss of rete pegs.
Muscle fibers are seen interspersed with thickened and dense collagen fibers.
¾ Group IVA: Advanced cases.
Trismus is severe with interincisal distance of less than 15 mm.
The fauces is thickened, shortened and firm to palpation.
Uvula is shrunken and appears as small, fibrous bud.
Tongue movements are limited.
On palpation of lips, circular band is felt around entire mouth.
¾ Group IVB: Advanced cases with premalignant and malignant changes.
Leukoplakia or squamous cell carcinoma can be seen.
o Histology:
Collagen hyalinized as a smooth sheet.
Extensive fibrosis obliterated the mucosal blood vessels and eliminated the
melanocytes.
Fibroblasts were markedly absent within the hyalinized zones.
Total loss of epithelial rete pegs.
Mild to moderate atypia present.
Extensive degeneration of muscle fibers is evident.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Lai DR, Chen HR and Huang YL et al (1995)33 classified OSF on the basis of mouth
opening as:
¾ Group A: Mouth opening greater than 35mm
¾ Group B: Mouth opening between 30-35mm
¾ Group C: Mouth opening between 20-30mm
¾ Group D: Mouth opening less than 20mm
Ranganathan K et al (2001)6 4 conducted a baseline study on the mouth opening
parameters of normal patients and divided the OSF patients as-
¾ Group I: Only symptoms. No restricted mouth opening.
¾ Group II: Limited mouth opening. 20mm and above.
¾ Group III: Mouth opening less than 20 mm.
¾ Group IV: OSF advanced with limited mouth opening.
Precancerous or cancerous changes seen throughout the mucosa.
Rajendran R (2003)59 reported the clinical features as follows:
¾ Early OSF: Burning sensation in the mouth. Blisters especially on the palatal
ulceration or recurrent generalized inflammation of oral mucosa, excessive salivation,
defective gustatory sensation and dryness of the mouth.
¾ Advanced OSF: Blanched and slightly opaque mucosa, fibrous bands in buccal
mucosa running in vertical direction. Palate and the faucial pillars are the areas first
involved. Gradual impairment of tongue movement occurs with difficulty in mouth
opening.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
PATHOPHYSIOLOGY
The pathogenesis of the disease is not well established, but is believed to have a
multifactorial cause. A number of factors trigger the disease process by causing a
juxtaepithelial inflammatory reaction in the oral mucosa29.
Canniff JP and Harvey W (1986)8 found that arecoline, an active alkaloid found in
betel nuts, stimulates fibroblasts to increase production of collagen by 150%.
Harvey W, Scutt A, Meghji S et al (1986)22 indicated that fibroblasts metabolize
arecoline to arecaidine, which may enhance fibroblast proliferation and thus increase
collagen. They proposed that flavanoid, catechin and tannin in betel nuts cause collagen
fibers to cross-link, making them less susceptible to collagenase. They found that OSF
remains active even after cessation of the chewing habit, suggesting that components of the
arecanut initiate OSF and then affect gene expression in the fibroblasts, which then produce
greater amounts of normal collagen.
Sheih TY and Yang JF (1992)7 2 conducted a study to examine the relationship
between the fibrosis and collagenase activity. Collagenase activity was determined by using
soluble 14C-glycine-labeled collagen as a substrate in a solution incubated for 30 hours at 35
degrees C. The results showed that the collagenase activity of OSF was much lower than that
of normal oral mucosa. They therefore suggested decreased secretion of collagenase as a
possible etiology for OSF.
Kuo MYP (1995)32 mentioned the production of collagen with more stable structure
(collagen type 1 trimer) as the reason for OSF.
Trivedy C (1999)79 suggested that upregulation of lysyl oxide may be an important
factor in the pathogenesis of OSF.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Tsai CC (1999)60 reported deficiency in collagen phagocytosis by OSF fibroblasts as
the possible cause of OSF.
Chiu CJ, Chang ML, Chiang CP et al (2002)13 reported that collagen fibers form a
three-dimensional scaffolding by combining cross-linked collagen molecules with other
extracellular matrix components. The terminal regions of each collagen molecule consist of
terminal peptides, which contain the sites of intra- and intermolecular cross-links. These
areas are resistant to attack by collagenases but can be attacked by a number of other serine
and cysteine proteinases. Collagenase activity has been found to be lower in OSF than in the
normal oral mucosa. This evidence implies that OSF may be considered a collagen-metabolic
disorder resulting from alkaloid exposure and individual variation in collagen metabolism.
Shieh DH, Chiang LC, Lee CH et al (2003)7 1 mentioned that increased mRNA
expression of TIMP-1 in buccal mucosa fibroblast by arecoline and safrole has a possible
role in the pathogenesis for oral submucous fibrosis.
Rajendran R (2003)5 9 associated genetic susceptibility with OSF because raised
frequencies of HLA-A10, B7 and DR3 were found in OSF patients compared to the normal
subjects.
Rajalalitha P and Vali S (2005)57 reviewed the autoregulatory pathway of TGF-ȕ,
which acts as the main trigger for both increased collagen production and decrease
degradation pathways, causing collagen deposition in the oral tissue, leading to fibrosis.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
HISTOPATHOLOGICAL FEATURES
Pindborg JJ and Sirsat SM (1966)55 reported juxta-epithelial chronic inflammatory
cell infiltration, strong fibroblastic response in lamina propria and thickened collagen bundles
in the connective tissue. Secondary to connective tissue changes there is an atrophic
epithelium, intercellular edema, basal cell hyperplasia, keratinisation and epithelial dysplasia.
They gave a histological grading for OSF:
o Very early stage: Finely fibrillar collagen dispersed with marked edema.
Plump young fibroblasts containing abundant cytoplasm. Blood vessels are
dilated and congested. Inflammatory cells, mainly polymorphonuclear
leukocytes with occasional eosinophils are found.
o Early stage: Juxtaepithelial area shows early hyalinization. Collagen still in
separate thick bundles. Moderate number of plump young fibroblasts is
present. Dilated and congested blood vessels are present. Inflammatory cells
are primarily lymphocytes, eosinophils and occasional plasma cells are
present.
o Moderately Advanced stage: Collagen is moderately hyalinised. Thickened
collagen bundles are separated by slight residual edema. Fibroblastic response
is less marked. Blood vessels are either normal or compressed. Inflammatory
exudate consists of lymphocytes and plasma cells.
o Advanced stage: Collagen is completely hyalinised. Smooth sheets with no
separate bundles of collagen are seen. Edema is absent. Hyalinised area is
devoid of fibroblasts. Blood vessels are completely obliterated or narrowed.
Inflammatory cells found are lymphocytes and plasma cells.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Canniff JP, Harvey W and Harris M (1986)8 analyzed 44 biopsies and reported
an atrophic epithelium with mild atypia, flattened epidermal\dermal junction and an
accumulation of collagen beneath the basement membrane.
Van Wyk CW, Seedat HA and Phillips VM (1990)85 examined the ultrastructural
features of the collagen in the moderate and advanced examples of OSF and found no
obvious abnormality of the collagen fibrils. They concluded that although there is an
excessive increase of collagen, especially Type I in OSF, the fibrils are still morphologically
normal.
Rajendran R, Radhakrishnan NS and Kartha CC (1993)6 0 observed thin
epithelium with ortho or parakeratinisation, with mild atypia. Rete ridges were blunt or
absent. Well defined basal membrane zone, with widened lamina propria with juxtaepithelial
fibrosis was seen. Connective tissue with chronic inflammatory cells was present. Small
arteries and fibrous tissue thick walled blood vessels were seen. Subepithelial fibrosis
extended deeper down into the muscle bundles. Extensive fatty infiltration was seen.
Chiu CJ , Chang ML, Chiang CP et a l (2002)13 stated that the main
histopathological characteristic of OSF is the deposition of collagen in the oral submucosa. It
has been found that alkaloid exposure of buccal mucosal fibroblasts may result in the
accumulation of collagen.
Rajendran R, Sunil, Twinkle SP et al (2004)6 0 reported a reduction in overall
thickness of the epithelium due to a decline in the number of mean cellular layers rather than
due to a diminution of the size of the cells in case of OSF.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Utsunomiya H, Tilakratne WM, Oshiro K et al (2005)84 histologically divided OSF
as:
o Early stage: Large number of lymphocytes in subepithelial zone along with
myxoedematous changes.
o Intermediate stage: Granulation changes close to the muscle layer and hyalinization
appears in subepithelial zone where blood vessels are compressed by fibrous bundles.
Reduced inflammatory cells in the subepithelial layer.
o Advanced stage: Inflammatory cell infiltrate hardly seen. Number of blood vessels
dramatically small in subepithelial zone. Marked fibrosis areas with hyaline changes
extending from subepithelial to superficial muscle layers. Atrophic, degenerative
changes start in muscle fibers.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
MATRIX METALLOPROTEINASES
Birkedal-Hansen H (1987)86 stated that the matrix metalloproteinases (MMPs) are a
family of enzymes secreted by resident and inflammatory cells that are collectively capable
of degrading most or all of the constituent macromolecules of the extracellular matrix.
HISTORY
Gross J and Lapiere CM (1962)19 produced a diffusible collagenolytic factor
operating at neutral pH and physiologic temperature on undernatured collagen, in Rana
Catesbiana tadpole’s tail fin tissues. Cultivation of bullfrog tadpole tissues on thermally
reconstituted neutral calf and guinea pig skin collagen gels resulted in degradation of the
substrate to dialyzable collagen peptides. They proposed that the experimental system used
by them could be developed into a quantitative assay for collagenolytic activity in small
tissue fragments.
Gross J and Nagai Y (1965)20 incubated thin strips of sterile living tadpole tail fin or
back skin on filter paper discs floating in amphibian Tyrode solution at 37°C for several
days. They observed that relatively large amount of collagenolytic enzyme appears in the
culture media. It had pH optimum 6-8, loses activity at 50-60°C after 10minutes and is
inhibited by ethylene diamine tetra acetic acid (EDTA) and cysteine. This enzyme, isolated
from tadpole tissue culture medium, cleaved native collagen molecules into two fragments
(one three-quarters and the other one-quarter the length of the molecule) at neutral pH and
physiologic temperatures without disrupting the helical structure of either of the two parts.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Lazarus GS, Brown RS and Daniels JR (1968)3 5 suggested a mechanism for
collagen degradation mediated by human granulocytic leukocytes. A specific collagenase,
which is extractable from human granulocytes, was partially purified chromatography. This
collagenolytic enzyme was operative at physiological pH and was inhibited by ethylene
diamine tetra acetic acid (EDTA), cysteine and reduced glutathione but not by human serum.
The enzyme cleaved the collagen molecule into two specific products, without loss of helical
conformation. Experiments with crude extracts from granulocytes suggested that the specific
products of granulocyte collagenase activity were then degraded by other proteases present in
the human granulocyte.
Harper E, Bloch KJ and Gross J (1971)21 identified the latent form of tadpole
collagenase, a zymogen which could be activated to its active form by an unknown factor.
Werb Z and Burleigh MC (1974)88 found that the latent collagenase in rabbit
fibroblast can be activated by organomercurials. Extracts of rabbit skin and synovium in
tissue culture secreted a specific collagenase into their culture media. Primary cultures of
fibroblast-like cells, which were obtained from these tissues and maintained in culture for up
to 14 subculture passages, also secreted high activities of a specific collagenase into serum-
free culture medium. Secretion of enzyme activity from the cell monolayer was at constant
rate for over 100 hours and continued for up to 8 days in serum-free culture medium. The
enzymic activity released was proportional to the number of cells in the monolayer. The
fibroblast collagenase was maximally active between pH 7 and 8. At 24°C the collagenase
decreased the viscosity of collagen in solution by 60%. The collagen molecule was cleaved
into three-quarters and one-quarter length fragments as demonstrated by electron microscopy
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
of segment-long-spacing crystallites and by polyacrylamide-gel electrophoresis of the
denatured products.
Werb Z, Banda MJ and Jones PA (1980)87 investigated the neutral and lysosomal
enzymes of mouse macrophages and indicated that the macrophages at inflammatory sites
contain and secrete proteolytic enzymes that could degrade the extracellular matrix.
Chin JR, Murphy G and Werb Z (1985)11 identified stromelysin, a connective
tissue degrading enzyme in parallel to collagenase.
Okada Y, Nagase H, Harris ED (1986)4 9 proposed the nomenclature Matrix
Metalloproteinases with the abbreviation MMP.
Murphy G, Cockett MI, Stephens PE et al (1987)46 identified metalloproteinase,
Stromelysin which can activate pro-collagenase.
Hasty KA, Stricklin GP, Hibbs MS et al (1987)23 compared the immunologic cross-
reactivity of human neutrophil and skin fibroblast collagenases, utilizing polyclonal antisera
prepared to purify enzymes. Polyclonal antisera from rabbits immunized with neutrophil
collagenase recognized fibroblast collagenase, as well as the neutrophil enzyme, when
analyzed by immunoblot techniques. The cross-reactive epitopes constituted a major
proportion of the antibody population, as shown by competitive inhibition of enzyme-linked
immunosorbent assay; 50% of the antibody to neutrophil collagenase was inhibited by skin
collagenase. Paradoxically, antisera to fibroblast collagenase failed to recognize the
neutrophil enzyme, either by immunoblot techniques or competitive inhibition enzyme-
linked immunosorbent assay, an observation which supports the notion that there are unique
immunodominant epitopes. The cross-reactivity with skin fibroblast collagenase shown by
the neutrophil antibody suggested a conservation of epitopes between collagenases of
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
different cellular origins. They opined that presence of epitopes unique for each enzyme
could lead to a feasible approach for investigating the differential contribution of various cell
types to collagenolytic activity in inflamed tissues.
Muller D, Quantin B, Gesnel MC et al (1988)45 reported that the collagenase gene
family in humans consists of at least four members who have several common structural
features, including an N terminal, a C terminal with hemopexin like domain, and a Zn
binding site.
William GSS (1996)70 identified a new member of MMP inhibitor family, tissue
inhibitor of MMPs (TIMP) -2.
Woessner FJ (1991)90 gave the recommended nomenclature and glossary of MMPs,
depending on their substrate specificity and broadly classified them as collagenase, gelatinase
and stromelysin. He proposed the name “Matrixin” for this family of proteases at the First
International Symposium on Matrix Metalloproteinases held at Destin, Florida, USA in Sept
1989. He listed the following as the chief characteristics of MMPs:
1. The catalytic mechanism depends on zinc at the active center.
2. The proteinases are secreted in zymogen form.
3. The zymogens can be activated by proteinases or by organomercurials.
4. The cDNA sequences all show homology to that of collagenase.
5. The enzymes cleave one or more components of the extracellular matrix.
6. Activity is inhibited by tissue inhibitor of metalloproteinases (TIMPs).
Pavloff N, Staskus PW, Kishnani NS et al (1992)52 identified the third member of
TIMP family from chick embryo fibroblast.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Sorsa T and Salo T (1994)75 showed that MMP-2 and MMP-9 were secreted by
stromal fibroblast during human mucosal wound healing.
Massova I, Kotra LP, Fridman R et al (1998)42 suggest that MMPs may be even
more ancient than previously thought, and could be traced before the emergence of
vertebrates from invertebrates; since the discovery of a similar metal-containing enzyme
from Bacteroides fragilis, which has been around for more than 3.5 billion years. They
reviewed that a total of 66 MMPs belonging to 23 distinct sub-groups have been sequenced
to date, of which 17 have been sequenced from humans, three from plants, three from
nematode Caenorhabditis elegans, and one each from Drosophila fly, sea urchin, hydra and
green algae. It is not clear how many MMPs exist in nature; many more are yet to be
discovered and sequenced.
Overall CM, King AE, Sam DK et al (1999)50 identified the TIMP-2 binding site on
hemopexin carboxyl domain of MMP-2.
Rao VH, Singh RK, Finnell RH et al (1999)66 listed the following as the
distinguishing characteristics of MMPs:
1. They are proteinases that degrade at least one component of the extracellular matrix.
2. They contain a zinc ion and are inhibited by chelating agents.
3. They are secreted in a latent form, requiring activation for proteolytic activity.
4. They are inhibited by TIMPs.
5. They share common amino acid sequences as revealed by molecular cloning.
Sorsa T, Salo T, Teronen O et al (2001)75 did “in vitro” studies on rat teeth and
showed that MMP inhibition significantly down-regulated dentinal caries lesion progression.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Chau I, Rigg A and Cunningham D (2003)10 reported that 20 MMPs have been
identified and these endopeptidases enzyme function at physiological temperature and pH,
and are either secreted or are membrane bound.
Mandal M, Mandal A, Das S et al (2003)40 reported that MMPs comprise of a large
family of endopeptidases, that share common structural and functional elements but are
products of a different gene.
Mantyla P, Kinane DF, Tikanoja S et al (2003)41 developed a sensitive, specific,
rapid and practical immunological chair-side dip-stick test for MMP-8 in gingival crevicular
fluid (GCF) and peri-implant sulcular fluid. The MMP-8 test stick is based on the
immunochromatography principle that uses two monoclonal antibodies specific for different
epitopes of MMP-8. One is immobilized into nitrocellulose membrane to form a catching
zone and other onto blue latex particles. This test can be performed by the dentist without
specific equipments and measures the GCF MMP-8 level in 5minutes. It differentiates
healthy and gingivitis sites from periodontitis sites.
Uitto VJ, Overall CM and McCulloch C (2003)83 opined that MMPs are often up-
regulated in groups forming activation cascades both in inflammatory and malignant
diseases.
Sorsa T, Tjaderhane L and Salo T (2004)75 reviewed the presence, activity,
function and regulation of MMPs in healthy and diseased oral tissues. They suggested the
role of collagenases, especially MMP-8 in periodontitis and peri-implantitis, as example for
unwanted tissue destruction related to increased presence and activity of MMPs at the site of
destruction. Evidences were also brought forward for involvement of MMP in other diseases
as dental caries and oral cancer.
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
Ylipalosaari M, Thomas GJ, Nystrom M et al (2005)92 using beta6-transfected and
control OSCC cells demonstrated that alphavbeta6 integrin down-regulates MMP-13
expression at both mRNA and protein level. Although expressing less MMP-13, beta6-
transfected cells have similar collagenolytic activity as control cells and invade at similar
levels through type I collagen. Growth of the tumour cells in organotypic culture and
confocal microscopy confirmed low levels of MMP-13 in cells with high alphavbeta6
expression. They suggested that alphavbeta6 down-regulates MMP-13 expression in oral
squamous cell carcinoma (OSCC) cells and that MMP-13 is not essential for the degradation
of type I collagen by OSCC cells.
STRUCTURE (Annexure 1-3)
MMPs are spherical strucWXUHV�FRPSRVHG�PDLQO\�RI�WZLVWHG�ILYH�VWUDQGHG�ȕ�VKHHWV�DQG�
WKUHH�Į�KHOLFHV��ZLWK�WZR�ELQGLQJ�VLWHV�HDFK�IRU�FDOFLXP�DQG�]LQF��7KH�VWUXFWXUDO�]LQF�IRUPV�D�
topknot for the sphere and is attached via three histidines and one asparagine to the catalytic
domain.
Mostly all the MMPs share a basic structure. This consists of-
1. a signal peptide \ prepeptide domain
2. a amino terminal propeptide domain that has to be cleaved to ensure enzyme
activity
3. a catalytic domain
4. a hinge \ linker domain
5. a C-terminal \ hemopexin domain
6. a trans membrane domain
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
COPY
RIG
HTED
to D
R. G
AURI
MIS
HRA
Illega
l to co
py o
r rep
rodu
ce in
any
form
at
1. Signal peptide domain-
It is rich in hydrophobic amino acids and directs MMP synthesis inside the cell. It is
removed before MMPs are secreted.
2. Propeptide domain-
The propeptide has a characteristic egg-like shape and contains a conserved sequence